Duloxetine for Multiple Sclerosis Pain

NCT00755807 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

239

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Duloxetine Hydrochloride (HCI)
DRUG: Placebo

Sponsor

Eli Lilly and Company